Traduction de «Valve inventory » (Anglais → Français) :

beginning inventory | initial inventory | initial stock | inventory brought forward from previous year | opening inventory | opening stock | starting inventory

make an inventory list | prepare an inventory list | make an inventory of fixtures | produce an inventory of fixtures

maintaining inventory of office supplies | sustain inventory of office supplies | keep inventory of office supplies in good condition | maintain inventory of office supplies

make inventory control accuracy | oversee inventory control accuracy | carry out inventory control accuracy | undertake inventory control accuracy

closing inventory | ending inventory | inventory carried forward to the following year

disk of a swing check valve | swing-type check mechanism | valve clack of a check valve | valve flap of a check valve

inventory turnover ratio [ inventory turnover | inventory utilization ratio | rate of inventory turnover | inventory turnover rate | stock turnover rate | inventory turns | stock turnover ]

valve-spring compressor | valve spring compressor | valve spring lifter | valve-spring lifter | valve spring tool | valve spring compressor tool | valve-spring compressor tool

days' sales in inventory | average age of inventory | days inventory held | days inventory outstanding | days to sell inventory | number of days' sales in average inventory | number of days' stock held

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...